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Abstract   
Introduction: 
Pigmentation disorders are common skin diseases caused by a wide range of 
etiologic factors such as pregnancy, sunshine and some drugs, for example 
minocycline etc. Vesicle-entrapped anti-hyperpigmentation agents can protect the 
therapeutic compounds from environmental destructive causes (light, oxygen and 
…) and they also provide a sustained release condition in the skin application of 
these medications. Hereby, we present the initial report, on the basis of our 
knowledge, on a niosomal preparation with two active pharmaceutical agents. 
. 
Methods and Results:  
Kojic acid (KA) and hydroquinone (HQ) were chosen as typical depigmentation 
agents. Many niosomal formulations were prepared by film hydration method in 
which co-encapsulation or separate entrapment of these compounds were evaluated. 
Span (20, 40, 60 or 80), Tween (20, 40, 60 or 80) and cholesterol were the main 
bilayer formation compounds and deionized water, normal saline and phosphate 
buffer were utilized as hydration media. A few formulations resulted in formation of 
stable multilamellar vesicles (MLVs) with high encapsulation efficiency of active 
agents. Therefore, we used direct mixing method for niosome formation which 
showed appropriate formulation properties with average volume diameter less than 
10 µm, high encapsulation efficiency and high protection ability for HQ against 
oxidation depicted as no color change was detected during the long term storage in 
open door jars. Release studies on prepared formulations showed a sustained drug 
delivery profiles for all vesicular formulations.  
 
Conclusions:  
Obtained results promised a new and appropriate drug delivery system for KA and 
HQ. Clinical trials with permitted ethical requirements should be done for 
application of these niosomes in topical niosomal gel, cream or lotion formulations. 
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